| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Reproductive Endocrinology |
Department of Pharmacology and Clinical Pharmacology (J.R., R.H., M.K.), University of Turku; Department of Obstetrics and Gynecology (L.A., T.P.), Turku University Central Hospital; Department of Clinical Chemistry (P.K., K.I.), Turku University Central Hospital, Turku, Finland
Address all correspondence and requests for reprints to: Dr. Juha Rouru, M.D., Department of Pharmacology and Clinical Pharmacology, University of Turku, Kiinamyllynkatu 10, FIN-20520 Turku, Finland. E-mail: juha.rouru{at}utu.fi
The role of gonadotropins, androgens, and insulin in the regulation of circulating leptin levels is obscure. In order to clarify the relationships of these parameters we studied serum leptin levels in 19 healthy control subjects and in 35 hyperandrogenic and hyperinsulinemic patients with polycystic ovary syndrome (PCOS).
Serum leptin concentrations did not differ significantly between PCOS patients and control subjects. When PCOS and control groups were analyzed together by univariate analysis, serum leptin was positively correlated with body mass index (BMI), body weight, serum insulin, serum triglyceride, and serum free testosterone concentrations. Serum leptin was inversely correlated with serum sex hormone binding globulin (SHBG) concentrations. There were no significant correlations between serum leptin and testosterone, androstenedione, or gonadotropin concentrations. Serum insulin, triglyceride, and free testosterone concentrations were positively correlated, and serum SHBG was negatively correlated with BMI. However, when BMI on one hand and serum insulin, triglyceride, free testosterone, or SHBG on other hand were used as independent variables in the partial correlation analysis with leptin, BMI turned out to be the variable primarily responsible for all of the correlations with leptin.
In conclusion, the concept that circulating leptin levels would be different in PCOS patients than in regularly menstruating control subjects is not supported by our data.
This article has been cited by other articles:
![]() |
R. Shroff, A. Kerchner, M. Maifeld, E. J. R. Van Beek, D. Jagasia, and A. Dokras Young Obese Women with Polycystic Ovary Syndrome Have Evidence of Early Coronary Atherosclerosis J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4609 - 4614. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.K. Ludwig, J.M. Weiss, S. Tauchert, T. Dietze, S. Rudolf, K. Diedrich, A. Peters, and K.M. Oltmanns Influence of hypo- and hyperglycaemia on plasma leptin concentrations in healthy women and in women with polycystic ovary syndrome Hum. Reprod., June 1, 2007; 22(6): 1555 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Glintborg, M. Andersen, C. Hagen, J. Frystyk, V. Hulstrom, A. Flyvbjerg, and A. P. Hermann Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. Eur. J. Endocrinol., August 1, 2006; 155(2): 337 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hahn, U. Haselhorst, B. Quadbeck, S. Tan, R. Kimmig, K. Mann, and O. E Janssen Decreased soluble leptin receptor levels in women with polycystic ovary syndrome Eur. J. Endocrinol., February 1, 2006; 154(2): 287 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Carmina, F Orio, S Palomba, T Cascella, R A Longo, A M Colao, G Lombardi, and R A Lobo Evidence for altered adipocyte function in polycystic ovary syndrome Eur. J. Endocrinol., March 1, 2005; 152(3): 389 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Norman, M. Noakes, R. Wu, M. J. Davies, L. Moran, and J. X. Wang Improving reproductive performance in overweight/obese women with effective weight management Hum. Reprod. Update, May 1, 2004; 10(3): 267 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Orio Jr., G. Matarese, S. Di Biase, S. Palomba, D. Labella, V. Sanna, S. Savastano, F. Zullo, A. Colao, and G. Lombardi Exon 6 and 2 Peroxisome Proliferator-Activated Receptor-{gamma} Polymorphisms in Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5887 - 5892. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Kero, E. Savontaus, M. Mikola, U. Pesonen, M. Koulu, R. A. Keri, J. H. Nilson, M. Poutanen, and I. T. Huhtaniemi Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E812 - E818. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. W. Wu and A. von Eckardstein Androgens and Coronary Artery Disease Endocr. Rev., April 1, 2003; 24(2): 183 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, S. M. Pincus, M. C. Garcia-Rudaz, M. G. Ropelato, M. E. Escobar, and M. Barontini Disruption of the Synchronous Secretion of Leptin, LH, and Ovarian Androgens in Nonobese Adolescents with the Polycystic Ovarian Syndrome J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3772 - 3778. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.M. Spritzer, M. Poy, D. Wiltgen, L.S. Mylius, and E. Capp Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements Hum. Reprod., July 1, 2001; 16(7): 1340 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Unkila-Kallio, S. Andersson, H.A. Koistinen, S.-L. Karonen, O. Ylikorkala, and A. Tiitinen Leptin during assisted reproductive cycles: the effect of ovarian stimulation and of very early pregnancy Hum. Reprod., April 1, 2001; 16(4): 657 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. MANTZOROS Role of Leptin in Reproduction Ann. N.Y. Acad. Sci., April 1, 2000; 900(1): 174 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S.Mantzoros, D. W.Cramer, R. F.Liberman, and R. L.Barbieri Predictive value of serum and follicular fluid leptin concentrations during assisted reproductive cycles in normal women and in women with the polycystic ovarian syndrome Hum. Reprod., March 1, 2000; 15(3): 539 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Imani, M. J. C. Eijkemans, F. H. de Jong, N. N. Payne, P. Bouchard, L. C. Giudice, and B. C. J. M. Fauser Free Androgen Index and Leptin Are the Most Prominent Endocrine Predictors of Ovarian Response during Clomiphene Citrate Induction of Ovulation in Normogonadotropic Oligoamenorrheic Infertility J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 676 - 682. [Abstract] [Full Text] |
||||
![]() |
T. L. Bützow, J. M. Moilanen, M. Lehtovirta, T. Tuomi, O. Hovatta, R. Siegberg, C.-G. Nilsson, and D. Apter Serum and Follicular Fluid Leptin during in Vitro Fertilization: Relationship among Leptin Increase, Body Fat Mass, and Reduced Ovarian Response J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3135 - 3139. [Abstract] [Full Text] |
||||
![]() |
M. Rosenbaum and R. L. Leibel Role of Gonadal Steroids in the Sexual Dimorphisms in Body Composition and Circulating Concentrations of Leptin J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1784 - 1789. [Full Text] |
||||
![]() |
T. Sir-Petermann, V. Piwonka, F. Perez, M. Maliqueo, S.E. Recabarren, and L. Wildt Are circulating leptin and luteinizing hormone synchronized in patients with polycystic ovary syndrome? Hum. Reprod., June 1, 1999; 14(6): 1435 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Mantzoros The Role of Leptin in Human Obesity and Disease: A Review of Current Evidence Ann Intern Med, April 20, 1999; 130(8): 671 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.E. Messinis, S.D. Milingos, E. Alexandris, I. Kariotis, G. Kollios, and K. Seferiadis Leptin concentrations in normal women following bilateral ovariectomy Hum. Reprod., April 1, 1999; 14(4): 913 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Agarwal, K. Vogel, S. R. Weitsman, and D. A. Magoffin Leptin Antagonizes the Insulin-Like Growth Factor-I Augmentation of Steroidogenesis in Granulosa and Theca Cells of the Human Ovary J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1072 - 1076. [Abstract] [Full Text] |
||||
![]() |
L. C. Morin-Papunen, R. M. Koivunen, C. Tomás, A. Ruokonen, and H. K. Martikainen Decreased Serum Leptin Concentrations during Metformin Therapy in Obese Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2566 - 2568. [Abstract] [Full Text] |
||||
![]() |
J. Licinio, A. B. Negrao, C. Mantzoros, V. Kaklamani, M.-L. Wong, P. B. Bongiorno, A. Mulla, L. Cearnal, J. D. Veldhuis, J. S. Flier, et al. Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women PNAS, March 3, 1998; 95(5): 2541 - 2546. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Karlsson, K. Lindell, E. Svensson, C. Bergh, P. Lind, H. Billig, L. M. S. Carlsson, and B. Carlsson Expression of Functional Leptin Receptors in the Human Ovary J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4144 - 4148. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Arroyo, G. A. Laughlin, A. J. Morales, and S. S. C. Yen Inappropriate Gonadotropin Secretion in Polycystic Ovary Syndrome: Influence of Adiposity J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3728 - 3733. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Caro Leptin Is Normal in PCOS, An Editorial about Three "Negative" Papers J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1685 - 1686. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |